- Home
- Equipment
- switzerland
- chemotherapy
Refine by
Chemotherapy Equipment Supplied In Switzerland
5 equipment items found
Manufactured by:Elthera AG based inSchlieren, SWITZERLAND
L1CAM expression increases the malignancy of these tumors by promoting cellular proliferation, metastatic spread, tumor angiogenesis, and resistance to chemotherapy. Accordingly, L1CAM-positive tumors show a highly malignant and invasive phenotype, leading to a poor prognosis for the affected patients. ...
Manufactured by:ICU Medical, Inc. based inSan Clemente, CALIFORNIA (USA)
Treating cancer patients takes compassion—it shouldn’t take a toll on your health. But the fact is, while chemotherapy is the backbone of medical oncology, these powerful medications—along with many others—are extremely toxic to the clinicians who handle them. Prolonged exposure to hazardous drug vapors, drips, or spills has been shown to lead to hair ...
Manufactured by:Cerbios-Pharma SA based inBarbengo – Lugano, SWITZERLAND
For over 40 years, Cerbios has been a worldwide market leader for the manufacture and supply of reduced Folates. Folates are a class of water soluble compounds belonging to the Vitamin B complex which are essential for a number of metabolic functions, including processes involved in the development and metabolism of CNS and the production of DNA and RNA, primarily in infancy, adolescence and ...
Manufactured by:InnoMedicus based inCham, SWITZERLAND
The Combat BRS System is an innovative bladder recirculation system designed to deliver. Combat BRS is an innovative bladder recirculation system for the treatment of non muscle invasive bladder carcinomas (NMIBC) with thermotherapy and cytostatic agents such as Mitomycin C, Epirubicin, etc. The patented system allows an effective heat exchange with a constant temperature of 43 ±0.5 ...
Manufactured by:AC BioScience SA based inEpalinges, SWITZERLAND
Our medical objective is to validate and bring to clinical use, a novel approach to improve the treatment of metastatic pancreatic adenocarcinoma using a proangiogenic molecule S1P lyase inhibitor acting as a tumor vascular ...